Cargando…
PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia
Overexpression of phosphatases of regenerating liver 2 (PRL2), detected in numerous diverse cancers, is often associated with increased severity and poor patient prognosis. PRL2-catalyzed tyrosine dephosphorylation of the tumor suppressor PTEN results in increased PTEN degradation and has been ident...
Autores principales: | Carlock, Colin, Bai, Yunpeng, Paige-Hood, Allison, Li, Qinglin, Nguele Meke, Frederick, Zhang, Zhong-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619439/ https://www.ncbi.nlm.nih.gov/pubmed/37665633 http://dx.doi.org/10.1172/jci.insight.170065 |
Ejemplares similares
-
Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis
por: Bai, Yunpeng, et al.
Publicado: (2016) -
Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia
por: Qu, Shuang, et al.
Publicado: (2014) -
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006) -
TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN
por: Qiu, Qiang, et al.
Publicado: (2023) -
PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling
por: Xu, Jianping, et al.
Publicado: (2019)